These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28095041)

  • 1. ORAL VERSUS TRANSDERMAL ESTROGEN IN TURNER SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Zaiem F; Alahdab F; Al Nofal A; Murad MH; Javed A
    Endocr Pract; 2017 Apr; 23(4):408-421. PubMed ID: 28095041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic effects of oral versus transdermal estrogen in growth hormone-treated girls with turner syndrome.
    Mauras N; Shulman D; Hsiang HY; Balagopal P; Welch S
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4154-60. PubMed ID: 17711924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic effects of oral versus transdermal 17β-estradiol (E₂): a randomized clinical trial in girls with Turner syndrome.
    Torres-Santiago L; Mericq V; Taboada M; Unanue N; Klein KO; Singh R; Hossain J; Santen RJ; Ross JL; Mauras N
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2716-24. PubMed ID: 23678038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of oral and transdermal 17β estradiol in girls with Turner syndrome.
    Taboada M; Santen R; Lima J; Hossain J; Singh R; Klein KO; Mauras N
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3502-10. PubMed ID: 21880799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
    Gravholt CH; Naeraa RW; Brixen K; Kastrup KW; Mosekilde L; Jørgensen JO; Christiansen JS
    Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugated oral versus transdermal estrogen replacement in girls with Turner syndrome: a pilot comparative study.
    Nabhan ZM; Dimeglio LA; Qi R; Perkins SM; Eugster EA
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2009-14. PubMed ID: 19318455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective evaluation of pubertal development and linear growth of girls with Turner Syndrome treated with oral and transdermal estrogen.
    Çakır ED; Sağlam H; Eren E; Özgür T; Tarım ÖF
    J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1219-26. PubMed ID: 25968434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Dosage of 17ß-Estradiol on Uterine Growth in Turner Syndrome-A Randomized Controlled Clinical Pilot Trial.
    Cleemann L; Holm K; Fallentin E; Møller N; Kristensen B; Skouby SO; Leth-Esbensen P; Jeppesen EM; Jensen AK; Gravholt CH
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31613320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for early initiation of growth hormone and transdermal estradiol therapies in girls with Turner syndrome.
    Davenport ML
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S91-7. PubMed ID: 16735135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are all estrogens created equal? A review of oral vs. transdermal therapy.
    Goodman MP
    J Womens Health (Larchmt); 2012 Feb; 21(2):161-9. PubMed ID: 22011208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Estrogen Therapies on Outcomes in Turner Syndrome: Assessment of Induction of Puberty and Adult Estrogen Use.
    Cameron-Pimblett A; Davies MC; Burt E; Talaulikar VS; La Rosa C; King TFJ; Conway GS
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2820-2826. PubMed ID: 30726925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
    Vrablik M; Fait T; Kovar J; Poledne R; Ceska R
    Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive effects on cardiovascular and breast metabolic markers of oral estradiol and dydrogesterone in comparison with transdermal estradiol and norethisterone acetate.
    Campagnoli C; Colombo P; De Aloysio D; Gambacciani M; Grazioli I; Nappi C; Serra GB; Genazzani AR
    Maturitas; 2002 Apr; 41(4):299-311. PubMed ID: 12034517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA; Farias ML; Andrade AT
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of transdermal and oral estrogen therapy in girls with Turner's syndrome.
    Jospe N; Orlowski CC; Furlanetto RW
    J Pediatr Endocrinol Metab; 1995; 8(2):111-6. PubMed ID: 7584704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosage of estradiol, bone and body composition in Turner syndrome: a 5-year randomized controlled clinical trial.
    Cleemann L; Holm K; Kobbernagel H; Kristensen B; Skouby SO; Jensen AK; Gravholt CH
    Eur J Endocrinol; 2017 Feb; 176(2):233-242. PubMed ID: 27881458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins.
    Walsh BW; Schiff I; Rosner B; Greenberg L; Ravnikar V; Sacks FM
    N Engl J Med; 1991 Oct; 325(17):1196-204. PubMed ID: 1922206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study.
    Bellantoni MF; Vittone J; Campfield AT; Bass KM; Harman SM; Blackman MR
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2848-53. PubMed ID: 8768841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid effects of an intrauterine levonorgestrel device or oral vs. vaginal natural progesterone in post-menopausal women treated with percutaneous estradiol.
    Suvanto-Luukkonen E; Sundström H; Penttinen J; Kauppila A
    Arch Gynecol Obstet; 1998; 261(4):201-8. PubMed ID: 9789651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.